US 12251445
Gamma-hydroxybutyrate delivering compounds and processes for making and using them
granted A61KA61K45/06A61K47/542
Quick answer
US patent 12251445 (Gamma-hydroxybutyrate delivering compounds and processes for making and using them) held by Zevra Therapeutics, Inc. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Zevra Therapeutics, Inc.
- Grant date
- Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K45/06, A61K47/542, A61K9/0048, A61P